ICON PLC (ICLR) — Technical state
As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 47 out of 100 (momentum 92 · quality 35 · valuation 47), as of 2026-11-11.
- Signal: Uptrend stack intact — Trades +15.7% vs the 50-day and +39.7% vs the 200-day average, 6.6% below the 52-week high and +207.4% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
- Trend: ICON PLC trades 15.7% above its 50-day and 39.7% above its 200-day moving average. (as of 2026-11-10)
ICON runs outsourced clinical trial and drug development work for pharmaceutical, biotech and device companies, covering the full path from early compound testing through Phase I-IV studies. It also offers laboratory testing, data analysis, site and patient access, and post-approval commercial support.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ICLR overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +15.7% vs the 50-day and +39.7% vs the 200-day average, 6.6% below the 52-week high and +207.4% off the 52-week low. Computed from daily closes.
Ranked #48 on today’s Directional Flow — Getting stronger list (scan of 2026-11-10).
The moving-average stack
- vs 20-day+6.3%
- vs 50-day+15.7%
- vs 200-day+39.7%
- 52-week band6.6% off the high · +207.4% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed up through the 50-day 19 sessions ago
- Stochastic%K 63.9 · %D 71.3 · bear cross
Continue: the ICLR chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-10
Quick answers
What is the current Closelooknet signal on ICLR?
Uptrend stack intact — Trades +15.7% vs the 50-day and +39.7% vs the 200-day average, 6.6% below the 52-week high and +207.4% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ICLR above its 50-day and 200-day moving averages?
As of 2026-11-10, ICON PLC trades +15.7% above its 50-day and +39.7% above its 200-day average, with the 20-day +6.3% away.
How far is ICLR from its 52-week high?
6.6% below the 52-week high and 207.4% above the 52-week low, as of 2026-11-10.
Mentioned on Closelooknet
Where ICLR appears in the diary — 2 pieces, newest first. Every link is our own writing.
Go deeper
Long reads
- Google and RSI — The Loop Nobody Has Closed
The International AI Safety Report 2026 devotes a section to it, and ICLR 2026 ran a workshop with recursive self-improvement in the title.
Dailies
- The Opex Handover — Why the AI Trade Is Rotating, Not Rolling Over
Google's KV-cache compression (ICLR 2026) cuts inference memory roughly 6× and speeds attention up to 8× on H100-class hardware — software-only, training-free, with no measurable accuracy loss.
Related in the Closelooknet universe
then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- MEDP Medpace Holdings Incindustry
- IDXX IDEXX Laboratories Incindustry
- ILMN Illumina Incindustry
- GH Guardant Health Incindustry
- NTRA Natera Incindustry
- CDNA CareDx Incindustry
- MTD Mettler-Toledo International Incindustry
- LH Labcorp Holdings Inc.industry
- CRL Charles River Laboratoriesindustry
- ADPT Adaptive Biotechnologies Corpindustry
- QGEN Qiagen NVindustry
- WAT Waters Corporationindustry
- TMO Thermo Fisher Scientific Incindustry
- DGX Quest Diagnostics Incorporatedindustry
- RDNT RadNet Incindustry
- OPK Opko Health Incindustry
- RVTY Revvity Inc.industry
- DHR Danaher Corporationindustry
- A Agilent Technologies Incindustry
- BLLN BillionToOne, Inc. Class A Common Stockindustry